Is Internet-based Self-help Effective for the Treatment of Insomnia Disorder?

Overview

The Swiss company mementor has recently developed an interactive self-help intervention for the treatment of insomnia entitled mementor somnium. This programme is based on the guidelines for cognitive-behavioural therapy. mementor somnium consists of 6 online sessions. An animated personal sleep coach provides relevant audio-information and asks questions to which the patient is invited to respond. The components of the programme flexibly adapt to the patient's responses. Aside from psycho-education, exercises and an instruction for sleep restriction, mementor somnium includes a cognitive restructuring intervention in terms of a Socratic dialogue. This Socratic dialogue, implemented by the animated sleep coach, is based on a complex algorithm in the shape of an decision tree. University of Zurich's Department of Psychology in Switzerland will test the effectiveness of mementor somnium in a randomised controlled trial with three assessment times (pre, 6-weeks post and 3-months follow-up). Patients suffering from insomnia will be allocated randomly to either the active intervention group or the waitlist control group. Participants will have access to the programme mementor somnium for six weeks. Primary outcome measure is the Insomnia Severity Index, secondary outcome measures are Beck Depressions-Inventory revised (BDI-II), Brief Symptom Inventory 18, and the SF-12 Health Survey. Additionally, sleep diary data will be collected.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2016

Interventions

  • Device: mementor somnium
  • Other: wait list
    • delayed access to mementor somnium

Arms, Groups and Cohorts

  • Experimental: Intervention
    • mementor somnium
  • Other: Waitlist

Clinical Trial Outcome Measures

Primary Measures

  • Insomnia Severity Index
    • Time Frame: Six weeks

Secondary Measures

  • Beck Depression Inventory
    • Time Frame: Six weeks
  • Brief Symptom Inventory 18
    • Time Frame: Six weeks
  • SF-12 Health Survey
    • Time Frame: Six weeks

Participating in This Clinical Trial

Inclusion Criteria

  • Insomnia Disorder (DSM-5) – German language comprehension – Internet-access Exclusion Criteria:

  • Other sleep disorder – Suicidality – Current psychotherapy – Drug abuse or recent change in medication

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Zurich
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.